Clinical Trial: Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With Obesity

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07824804) titled 'Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With Obesity' on Sept. 12.

Brief Summary: This study is a randomized, double-blind, placebo-controlled, single-dose, dose-escalation Phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MWN117 injection in healthy and obese Chinese participants.

The study consists of two parts. Part A includes two dose cohorts enrolling healthy participants, and Part B includes four dose cohorts enrolling obese participants. A total of 48 participants will be enrolled. Within each dose cohort, participants will be r...